Indication

Relapsed or Refractory Peripheral T Cell Lymphoma

1 clinical trial

1 product

Clinical trial

A Phase I/II, Open-Label, Multicentre Study to Investigate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD4205 in Patients With Peripheral T Cell Lymphoma (PTCL)

Status: Completed, Estimated PCD: 2023-10-12

Product